Abstract A05: Expansion of tumor-infiltrating lymphocytes (TIL) using Iovance's Gen 2 process from advanced bladder cancer for adoptive immunotherapyQiang Li, Gurkamal Chatta, Amit A. Lugade et al.|Clinical Cancer Research|2020Cited by 0